use of a pharmaceutically acceptable compound or derivative thereof, methods for killing clinically latent microorganisms in a mammal, for treating or preventing a microbial infection in a mammal, for sterilizing an object, for preserving an inorganic or organic material, for treating a disease , to reduce the dose of conventional antimicrobial agent required to treat a microbial infection and to treat a protozoan disease in a mammal, combined product, formulation, use of a combined product, compound, and process for preparing it.

摘要

USE OF A COMPOUND OR A DERIVATIVE OF THE SAME PHARMACEUTICALLY ACCEPTABLE, METHODS TO KILL CLINICALLY LATENT MICROORGANISMS, TO TREAT OR PREVENT MICROBIAN INFECTION IN A MAMMER, TO STERILIZE OR ORGANIZATIONAL FOR A STERILIZATION OF A MATERIAL , TO REDUCE THE CONVENTIONAL ANTIMICROBIAN AGENT DOSE REQUIRED TO TREAT A MICROBIAN INFECTION AND TO TREAT A PROTOZOAN DISEASE IN A MAMMAL, FORMULATION, USE OF A COMBINED PRODUCT, COMPOUND, COMPOUND, PROCESS, COMPOSITE. The use of compounds of formula (I), wherein R 2 R 2 R 3 and X have the meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms is provided. The use of compounds of formula (I) to treat microbial infections as well as certain compounds of formula (I) per se is also provided.